⌘K

Login Start Free

Home/Filings/4/0001516551-23-000092

4//SEC Filing

TYLE PRAVEEN 4

Accession 0001516551-23-000092

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 8:29 PM ET

Size

5.6 KB

Accession

0001516551-23-000092

Insider Transaction Report

Form 4

Period: 2023-11-06

Skye Bioscience, Inc.SKYE

Director

Transactions

Award
Stock Option (Right to Buy)
2023-11-06+14,110→ 20,001 total
Exercise: $3.50Exp: 2033-08-25→ Common Stock (14,110 underlying)

Footnotes (1)

[F1]The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023.

Documents

1 file

4
wk-form4_1699320545.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0001296936

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 8:29 PM ET
Size: 5.6 KB

View on SEC.gov